Skip to content

Effect of different doses of sufentanil on the quality of stress and postoperative awakening in pediatric laryngeal mask general anesthesia

Effect of different doses of sufentanil on the quality of stress and postoperative awakening in pediatric laryngeal mask general anesthesia

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500110675
Enrollment
Unknown
Registered
2025-10-17
Start date
2026-01-26
Completion date
Unknown
Last updated
2025-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Children's fiber bronchoscopy

Interventions

Group A:Sufentanil at a dose of 0.15 µg/kg was administered during anesthesia induction
Group B:Sufentanil at a dose of 0.2 µg/kg was administered during anesthesia induction
Group C:Sufentanil at a dose of 0.15 µg/kg was administered during anesthesia induction

Sponsors

Shandong Provincial Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 6 Years

Inclusion criteria

Inclusion criteria: 1?The diagnosis is clear and all meet the indications for bronchoscopy; 2?Age 3 to 6 years old; 3?ASA grade I to II.

Exclusion criteria

Exclusion criteria: 1? Congenital diseases; 2?Combined mental diseases; 3? abnormal heart function or coagulation disorder; 4? Auditory and language communication disorders; 5? There are contraindications or intolerance of surgery; 6? History of allergic to anesthetic drugs;

Design outcomes

Primary

MeasureTime frame
Vital signs of children at each time point;The quality of the child patient's awakening;

Secondary

MeasureTime frame
The incidence of intraoperative adverse events (incidence of adverse reactions: choking cough, body movement response);The dosage of remifentanil;The dosage of propofol;time of operation;Satisfaction of endoscopy doctors;

Countries

China

Contacts

Public Contactchanglin liu

Shandong Provincial Third Hospital

liuchanglin0901@163.com+86 135 8313 0103

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026